Amanda Moore (@Appendicure) header
Amanda Moore (@Appendicure) profile picture

APPENDICURE is a patient-centered initiative dedicated to raising awareness, funding research, and empowering those affected by appendix cancer.

United States
Joined November 2025
Appendix cancer research has a time problem. A promising idea can wait a year or more for a grant before anyone tests it. We decided not to wait. Appendicure is funding a full year of lab testing at Johns Hopkins. The idea came from data scientist and caregiver Ricki Dhal. His AI platform re-analyzed single-cell data from about 470,000 cells and found a distinct polyamine pattern in PMP. (Ricki is an unpaid Appendicure board member.) That pointed to a two-drug combination never tested in PMP or high-grade appendix cancer. Dr. Tracy Murray Stewart's lab at the Johns Hopkins Kimmel Cancer Center, which specializes in polyamine research, is now testing it. To be clear: this is early lab work on cells, not a clinical trial. It is the first step. We will share every result, good or bad, with updates every two weeks. The year of testing costs $80,000, being raised by patients, caregivers and friends. Help us finish it: givebutter.com/support-appen… #AppendixCancer #PMP #RareCancer
1
4
28
On October 28, I gave public comment at the FDA’s Rare Disease Framework meeting on behalf of Appendicure. Modern cancer drugs target mutations, but clinical trials still sort patients by where the tumor started. Many appendix cancer and PMP patients carry KRAS or GNAS mutations, the same targets being studied in pancreatic and colorectal cancer trials, yet they’re often excluded because their cancer began in the appendix. I asked the FDA to move clinical trials into the modern age and give rare cancers the same early planning now required for children with cancer; to require sponsors to explain why they exclude rare cancers when the science supports including them, and to bring patients and caregivers into the process early. Nobody should have to fight their way into a trial. Watch the full comment here: youtu.be/Z5uvsytw6Jc
1
2
37
Amanda Moore retweeted
RAS inhibitors in clinical development From @papkephd’s website: rasinhibitors.com
1
49
3
168
15,226
Appendix Cancer Finally Gets Its Own Spotlight appendicure.com/2025/11/06/a…
14